Yehuda Chowers

18.2k total citations · 2 hit papers
182 papers, 9.4k citations indexed

About

Yehuda Chowers is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Yehuda Chowers has authored 182 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Genetics, 69 papers in Epidemiology and 61 papers in Immunology. Recurrent topics in Yehuda Chowers's work include Inflammatory Bowel Disease (96 papers), Microscopic Colitis (56 papers) and Immunodeficiency and Autoimmune Disorders (29 papers). Yehuda Chowers is often cited by papers focused on Inflammatory Bowel Disease (96 papers), Microscopic Colitis (56 papers) and Immunodeficiency and Autoimmune Disorders (29 papers). Yehuda Chowers collaborates with scholars based in Israel, United States and France. Yehuda Chowers's co-authors include Shomron Ben‐Horin, Uri Kopylov, Rami Eliakim, Orit Picard, Ella Fudim, Miri Yavzori, Bella Ungar, Simon Bar–Meir, Herma H. Fidder and Simon Travis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Yehuda Chowers

178 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

2012 638 citations Rami Eliakim, Yehuda Chowers et al. Journal of Crohn s and Colitis profile →
Review article: loss of response to anti-TNF treatments in Crohn’s disease

2011 494 citations Shomron Ben‐Horin, Yehuda Chowers profile →

Peers

Countries citing papers authored by Yehuda Chowers

Since Specialization

Citations

This map shows the geographic impact of Yehuda Chowers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yehuda Chowers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yehuda Chowers more than expected).

Fields of papers citing papers by Yehuda Chowers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yehuda Chowers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yehuda Chowers. The network helps show where Yehuda Chowers may publish in the future.

Co-authorship network of co-authors of Yehuda Chowers

This figure shows the co-authorship network connecting the top 25 collaborators of Yehuda Chowers. A scholar is included among the top collaborators of Yehuda Chowers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yehuda Chowers. Yehuda Chowers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adverse obstetric outcomes in cases of meconium-stained amniotic fluid complicated with intrapartum fever 2024 ·Archives of Gynecology and Obstetrics ·Hanoch Schreiber, Gal Cohen, (unknown), (unknown), Tal Biron‐Shental, Yehuda Chowers, Michal Kovo	1
2	Preventing nosocomial bloodstream infections (NBSIs) by implementing hospitalwide, department-level, self-investigations: A NBSIs frontline ownership intervention 2023 ·Infection Control and Hospital Epidemiology ·(unknown), Yehuda Chowers, Elizabeth Temkin, Pnina Shitrit	1
3	Durability of the First Biologic in Patients with Crohn’s Disease: A Nationwide Study from the epi-IIRN 2023 ·Journal of Crohn s and Colitis ·Ohad Atia, (unknown), Gili Focht, (unknown), (unknown), Shira Greenfeld, Amir Ben‐Tov, Yiska Loewenberg Weisband, Eran Matz, Yuri Gorelik, Yehuda Chowers, Iris Dotan, Dan Turner	6
4	Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRN 2023 ·Journal of Crohn s and Colitis ·Yuri Gorelik, (unknown), (unknown), (unknown), (unknown), Yiska Loewenberg Weisband, Shira Greenfeld, Revital Kariv, (unknown), Eran Matz, Iris Dotan, Haggai Bar‐Yoseph, Yehuda Chowers, Dan Turner	2
5	Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN 2021 ·Gut ·Yuri Gorelik, (unknown), (unknown), Sigal Pressman, (unknown), (unknown), Gili Focht, Yiska Loewenberg Weisband, Shira Greenfeld, Revital Kariv, (unknown), Iris Dotan, Naama Geva‐Zatorsky, Shai S. Shen-Orr, Yechezkel Kashi, Yehuda Chowers	17
6	Improved Outcomes of Paediatric and Adult Crohn’s Disease and Association With Emerging Use of Biologics–A Nationwide Study From the Epi-IIRN 2021 ·Journal of Crohn s and Colitis ·Ohad Atia, Esther Orlanski‐Meyer, (unknown), (unknown), Shira Greenfeld, Revital Kariv, Saleh Daher, Henit Yanai, Yiska Loewenberg Weisband, (unknown), Eran Matz, Daniel Nevo, Eran Israeli, Doron Schwartz, Yehuda Chowers, Iris Dotan, Dan Turner	19
7	Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN 2021 ·Journal of Crohn s and Colitis ·Ohad Atia, Esther Orlanski‐Meyer, (unknown), (unknown), Shira Greenfeld, Revital Kariv, Saleh Daher, Henit Yanai, Yiska Loewenberg Weisband, (unknown), Eran Matz, Daniel Nevo, Jacob E. Ollech, Eran Zittan, Eran Israeli, Doron Schwartz, Yehuda Chowers, Iris Dotan, Dan Turner	30
8	Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience 2018 ·Digestive and Liver Disease ·Uri Kopylov, Irit Avni‐Biron, Yulia Ron, Benjamin Koslowsky, Matti Waterman, Saleh Daher, Bella Ungar, Doron Schwartz, Eran Zittan, (unknown), Henit Yanai, Nitsan Maharshak, (unknown), Timna Naftali, Rami Eliakim, Yehuda Chowers, Shomron Ben‐Horin, Iris Dotan	21
9	Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction 2017 ·Gut ·(unknown), Alexandra Blatt, Yael Danin‐Poleg, (unknown), Edmond Sabo, (unknown), Shahar Daniel, Aviva Dahan, Oren Ziv, Rishu Dheer, María T. Abreu, Omry Koren, Yechezkel Kashi, Yehuda Chowers	219
10	Early histological findings may predict the clinical phenotype in Crohn’s colitis 2016 ·United European Gastroenterology Journal ·Amir Klein, Yoav Mazor, Amir Karban, Ofer Ben‐Itzhak, Yehuda Chowers, Edmond Sabo	17
11	Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines 2016 ·Clinical Gastroenterology and Hepatology ·Haggai Bar‐Yoseph, Matti Waterman, Ronit Almog, Thomas Billiet, Séverine Vermeire, Bella Ungar, Henit Yanai, Iris Dotan, Shomron Ben‐Horin, Yehuda Chowers	20
12	Celiac Disease Resolution After Allogeneic Bone Marrow Transplantation is Associated with Absence of Gliadin-Specific Memory Response by Donor-Derived Intestinal T-cells 2013 ·Journal of Clinical Immunology ·Shomron Ben‐Horin, Sylvie Polak‐Charcon, Iris Barshack, Orit Picard, Ella Fudim, Miri Yavzori, Camila Avivi, (unknown), Avichai Shimoni, Yehuda Chowers, ‪Yasmin Maor‬‏	7
13	Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health 2011 ·Gut ·Laurent Peyrin‐Biroulet, Alarcos Cieza, William J. Sandborn, Michaela Coenen, Yehuda Chowers, Toshifumi Hibi∥, Nenad Kostanjsek, Gerold Stucki, Jean–Frédéric Colombel, (unknown)	259
14	The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn’s disease 2009 ·Cellular Immunology ·Avivit Ochaion, S. Bar‐Yehuda, Shira Cohen, Faina Barer, R. Patoka, Howard Amital, Tatiana Reitblat, (unknown), J. Ophir, (unknown), Yehuda Chowers, Shomron Ben‐Horin, Pnina Fishman	104
15	Functional Voltage-Gated Sodium Channels Are Expressed in Human Intestinal Epithelial Cells 2008 ·Digestion ·Iris Barshack, Mia Levite, Alon Lang, Ella Fudim, Orit Picard, Shomron Ben‐Horin, Yehuda Chowers	21
16	Familial clustering of Crohnʼs disease in Israel: Prevalence and association with disease severity 2008 ·Inflammatory Bowel Diseases ·Shomron Ben‐Horin, Benjamin Avidan, Henit Yanai, Alon Lang, Yehuda Chowers, Simon Bar–Meir	30
17	The Bsm I Vitamin D Receptor Gene Polymorphism Is Associated with Ulcerative Colitis in Jewish Ashkenazi Patients 2004 ·Genetic Testing ·Rivka Dresner–Pollak, Zvi Ackerman, Rami Eliakim, Amir Karban, Yehuda Chowers, Herma H. Fidder	56
18	Somatostatin Through Its Specific Receptor Inhibits Spontaneous and TNF-α- and Bacteria-Induced IL-8 and IL-1β Secretion from Intestinal Epithelial Cells 2000 ·The Journal of Immunology ·Yehuda Chowers, Liora Cahalon, Maor Lahav, Hagai Schor, Ruth Tal, Simon Bar–Meir, Mia Levite	98
19	Budesonide versus prednisone in the treatment of active Crohn's disease 1998 ·Gastroenterology ·Simon Bar–Meir, Yehuda Chowers, Alexandra Lavy, (unknown), A Sternberg, (unknown), Ron Reshef, Shmuel Odes, (unknown), (unknown), Rami Eliakim, Eran Maoz, U. Mittmann	170
20	Scabies-Associated Angioimmunoblastic Lymphadenopathy 1986 ·Acta Haematologica ·(unknown), Yehuda Shoenfeld, Yehuda Chowers, Jed Goldstein, A Keynan	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact